Evidence map›Paper›PMID 38067330›Full record

ReviewCancers2023

Review and Updates on Systemic Mastocytosis and Related Entities.

Julie Y Li, Christopher B Ryder, Hailing Zhang, Samuel G Cockey, Elizabeth Hyjek, Lynn C Moscinski, Elizabeth Sagatys, Jinming Song

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Julie Y LiDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Christopher B RyderDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Hailing ZhangDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Samuel G CockeyMorsani College of Medicine, University of South Florida Health, Tampa, FL 33602, USA.ORCID 0000-0002-9034-0273
Elizabeth HyjekDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Lynn C MoscinskiDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Elizabeth SagatysDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Jinming SongDepartment of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Moffitt Cancer Center · USUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cell disorders range from benign proliferations to systemic diseases that cause anaphylaxis and other diverse symptoms to mast cell neoplasms with varied clinical outcomes. Mastocytosis is the pathologic process of the accumulation of abnormal mast cells in different organs, mostly driven by

Indexed as

classificationdiagnosishereditary alpha-tryptasemia (HαT or HAT)KITmast cell activation syndrome (MCAS)molecularsystemic mastocytosis (SM)the International Consensus Classification (2022 ICC)treatmentWHO 5th Edition Classification of Haematolymphoid Tumours (WHO 5th edition)

Identifiers

PMID38067330
PMCPMC10705510
OpenAlexW4389144191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.